Tower Research Capital LLC (TRC) - INVIVO THERAPEUTICS HLDGS CO ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q3 2023$8,504
-14.8%
7,593
+2.7%
0.00%
Q2 2023$9,978
+498800.0%
7,391
+314.3%
0.00%
Q1 2023$2
-83.3%
1,784
-65.3%
0.00%
Q4 2022$12
-99.8%
5,147
+193.8%
0.00%
Q3 2022$7,000
+75.0%
1,752
+95.5%
0.00%
Q2 2022$4,0008960.00%
Other shareholders

There were no reported owners of INVIVO THERAPEUTICS HLDGS CO in Q4 2023.

NameSharesValueWeighting ↓
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders